<?xml version="1.0"?>
<Articles JournalTitle="The Research in Heart Yield and Translational Medicine (RHYTHM)">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>13</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2018</Year>
        <Month>10</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">First Experience with Extracorporeal Membrane Oxygenation in Iran, under Difficult Conditions</title>
    <FirstPage>166</FirstPage>
    <LastPage>172</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Zargham Hossein</FirstName>
        <LastName>Ahmadi</LastName>
        <affiliation locale="en_US">Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Farshid</FirstName>
        <LastName>Salehi</LastName>
        <affiliation locale="en_US">Tracheal Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Shanay</FirstName>
        <LastName>Niusha</LastName>
        <affiliation locale="en_US">Tracheal Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Raoufy</LastName>
        <affiliation locale="en_US">Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Behrooz</FirstName>
        <LastName>Farzaneghan</LastName>
        <affiliation locale="en_US">Nursing and Respiratory Health Management Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Afshar</LastName>
        <affiliation locale="en_US">Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Yadollah</FirstName>
        <LastName>Mafhoomi</LastName>
        <affiliation locale="en_US">Nursing and Respiratory Health Management Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Faghih Abdollahi</LastName>
        <affiliation locale="en_US">Nursing and Respiratory Health Management Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Golnar</FirstName>
        <LastName>Radmand</LastName>
        <affiliation locale="en_US">Anesthesiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Ansari Aval</LastName>
        <affiliation locale="en_US">Pediatric Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Jahangirifard</LastName>
        <affiliation locale="en_US">Tracheal Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>10</Month>
        <Day>01</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>08</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Extracorporeal membrane oxygenation (ECMO) provides hemodynamic and oxygenation support in critical conditions. The commencement of this modality in Iran coincided with severe economic constraints across Iran. 
Methods: This retrospective study was performed in Masih Daneshvari Medical Center from 2010 to 2015, during which period, sanction-related limitations in the import of equipment prompted us to integrate a Medtronic or St&#xF6;ckert head pump console into a Maquet ECMO Oxygenator so as to sustain the ECMO program. Comparisons were performed between successful and unsuccessful ECMO procedures and survivors. Factors associated with unsuccessful ECMO were evaluated with a multivariate logistic regression. 
Results: Thirty-three (68.8%) patients were male and 15 (31.2%) were female. The mean age of the patients was 35&#xB1;16.6 years. Thirty-seven (77.1%) patients were weaned off ECMO successfully; the rate was higher than that in previous studies. Totally, 35.4% of the study population survived to hospital discharge. The most common cause of death in all the ECMO patients who were successfully weaned was sepsis. The most common cause of death in the patients who underwent unsuccessful ECMO was multisystem organ failure. The mean ECMO support time was 53.37&#xB1;46.26 hours. The patients who were alive at discharge were significantly younger (25.5&#xB1;14.5 vs. 40.2&#xB1;15.5 y; P=0.002) and had a significantly lower ECMO duration (24 [25&#x2013;75% interquartile: 18.5&#x2013;36] vs. 48 [25&#x2013;75% interquartile: 24&#x2013;72] h; P=0.044) than the non-survivors.
Conclusion: An assembly of ECMO components from different companies could be done safely, at least for a short period of time.</abstract>
    <web_url>https://rhythm.tums.ac.ir/index.php/jthc/article/view/782</web_url>
    <pdf_url>https://rhythm.tums.ac.ir/index.php/jthc/article/download/782/800</pdf_url>
  </Article>
</Articles>
